Scholars Central

Conference abstractPublished 12 Nov 2013

Safety and potency test for PV and ERA based cell culture anti-rabies vaccine produced in Ethiopia

Authors: Abebe Mengesha

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Two rabies vaccinal strains (PV and ERA) used to produce virus suspension propagated on Vero and BHK-21 cell lines in Ethiopia. Potency and safety of the vaccine studied after inactivation with formalin. Safety test performed to access if the vaccine have residual virulent left during inactivation or to detect any bacteriological contaminant present in the crude vaccine. According to the test, no residual virus or bacterial contaminant detected. Potency test determines the degree of protection conferred by the vaccine in immunized mice challenged with challenge virus strain. This test was performed using National Institutes of Health (NIH) potency test. Mice were immunized at day 0 and 7 with five different concentrations of test vaccine and four different concentrations of control vaccine, 16 mice in each dilution. The control vaccine used was VeroRab vaccine which was produced by Sanofi Pasteur. Standard CVS strain obtained from CDC was used as challenge virus. Mice were challenged on 14th day of immunization with challenge virus strain (CVS-11) of 25 MLD50/0.03 ml intra-cerebrally. The mice were observed for 14 days after challenging and death recorded for each dilution separately. Potency result calculated using NIH test and 8.32IU/ ml for ERA and 2.5 IU/ml for PV results were obtained. Based on WHO recommendation, these vaccines have high potency and upon dilution can be used for animal immunization

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Developing Drugs.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Developing Drugs
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Abebe Mengesha”